P
CELC icon

Pfizer’s Celcuity CELC Stock Holding History

Pfizer’s Portfolio CELC Stock Details CELC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.6M Hold
295,652
– – 17.35% 2
2026
Q1 		$31.3M Sell
295,652
-53,754
-15% -$5.86M 13.13% 4
2025
Q4 		$34.8M Hold
349,406
– – 14.74% 3
2025
Q3 		$17.3M Hold
349,406
– – 3.95% 6
2025
Q2 		$4.66M Hold
349,406
– – 0.81% 12
2025
Q1 		$3.53M Hold
349,406
– – 0.71% 12
2024
Q4 		$4.57M Buy
+349,406
New +$4.93M 0.18% 14

Other funds holding CELC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Pfizer's CELC Position: Q2 2026 in Review

Pfizer held its Celcuity (CELC) position steady in Q2 2026 at 295,652 shares worth $29.6M. The position accounts for 17.35% of the portfolio, ranked #2.

Pfizer first reported a position in CELC in Q4 2024 and has held it in 7 quarters since. The position peaked at $34.8M in Q4 2025. 274 funds tracked by Wall St. Rank hold CELC as of Q2 2026.

  • Pfizer held 295,652 shares of Celcuity worth $29.6M as of Q2 2026.
  • Pfizer left its Celcuity share count unchanged in Q2 2026.
  • Celcuity made up 17.35% of Pfizer's portfolio in Q2 2026, its #2 holding.
  • Pfizer first reported a position in Celcuity in Q4 2024 and has held it in 7 quarters since.
  • Pfizer's Celcuity position peaked at $34.8M in Q4 2025.
  • 274 funds tracked by Wall St. Rank held Celcuity as of Q2 2026.

Based on Pfizer's 13F filing for Q2 2026, filed 13 Aug 2026.